Startup Roundup: Antithesis Foods, Guard Medical, C2i, Bactana
June 7, 2022
Three Cornell-licensed startups and one Cornell eLab student accelerator company are paving the way to success.
NSF awards $1M to Cornell snack startup Antithesis Foods
It began as a Cornell classroom project and has blossomed into student startup company. Now, the National Science Foundation has awarded a nearly $1 million small-business grant to Antithesis Foods for its novel invention to make healthy snack foods and crunchy ingredients from chickpeas and other legumes – all low-calorie, high-fiber and high-protein.
The funding advances a nutrient-dense, crunchy ingredient to get healthier snacks such as graham crackers, cereals, chips, granola and cookies on supermarket shelves.
Guard Medical raises $11M in Series B investments
Guard Medical Inc. has raised a Series B investment of $11 million to support commercialization and clinical studies for its product NPseal, a negative pressure wound therapy dressing for closed incisions. The Series B completion was announced April 6.
C2i launches disease test in Europe
C2i Genomics, a cancer intelligence company using software licensed through CTL, launched its C2inform minimal residual disease test across Europe.
The C2inform test applies whole-genome sequencing and artificial intelligence to a 3 to 4 milliliter blood sample, which supports rapid and accurate detection of cancer, monitors disease progression and evaluates therapeutic efficacy, according to the company.
Bactana receives NSF business grant
The NSF has awarded Bactana Corp., a company that graduated from Cornell’s Kevin M. McGovern Family Center for Venture Development in the Life Sciences business incubator three years ago, a Small Business Innovation Research (SBIR) Phase I grant to expand research and development for a bacteria-derived therapeutic drug.
Learn more about Startup Roundup: Antithesis Foods, Guard Medical, C2i, Bactana on the Chronicle.